Paroxysmal Atrial Fibrillation
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age >=18; 2. Symptomatic paroxysmal atrial fibrillation undergoing pulmonary vein isolation (PVI) ablation for the first time; 3. Sign the informed consent form;
Exclusion criteria
Exclusion criteria: 1. Reversible atrial fibrillation (e.g., electrolyte imbalance, hyperthyroidism); 2. Previous history of cardiac surgery (previous radiofrequency ablation/all other cardiac surgeries); 3. Severe comorbidities (unstable angina, heart failure, life expectancy < 1 year); 4. Contraindications to radiofrequency ablation for atrial fibrillation, such as left atrial/left atrial appendage thrombus, uncontrolled severe bleeding risk (according to the Chinese Guidelines for the Diagnosis and Treatment of Atrial Fibrillation 2023);
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Dosage of sedative drugs: total dose of Midazolam (µg), total dose of Fentanyl (µg), intraoperative administration rate (total dose / surgical duration);;VAS Score;model displacement volume;; | — |
Secondary
| Measure | Time frame |
|---|---|
| immediate pulmonary vein isolation success rate, single-circle isolation success rate (whether additional ablation points are needed);;operation time (total duration, radiofrequency time, fluoroscopy time);;peripheral injection fluid intake, ablation catheter fluid usage;;other data such as patient baseline characteristics (age, gender, CHA2DS2-VASc score), body weight and BMI, intraoperative vital signs (blood pressure, oxygen saturation);occurrence of intraoperative complications, side effects of anesthetic drugs (e.g., respiratory depression, nausea and vomiting);; | — |
Countries
China
Contacts
Ningbo Medical Centre Lihuili Hospital